New advances in the management of a long-neglected disease.
Urbina
Julio A
JA
D000328:Adult; D000818:Animals; D001838:Bolivia; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism; D014355:Chagas Disease / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy* / Q000276:immunology* / Q000469:parasitology / Q000635:transmission*; D016054:DNA, Protozoan / Q000235:genetics; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D007371:Interferon-gamma / Q000378:metabolism; D007376:Interleukin-2 / Q000378:metabolism; D008875:Middle Aged; D009593:Nitroimidazoles / Q000627:therapeutic use*; D016133:Polymerase Chain Reaction; D011247:Pregnancy; D013601:T-Lymphocytes / Q000276:immunology / Q000378:metabolism; D016896:Treatment Outcome; D014344:Trypanocidal Agents / Q000627:therapeutic use*; D014349:Trypanosoma cruzi / Q000235:genetics / Q000276:immunology / Q000502:physiology*; D055815:Young Adult
D016054:DNA, Protozoan; D007376:Interleukin-2; D009593:Nitroimidazoles; D014344:Trypanocidal Agents; D007371:Interferon-gamma; C009999:benzonidazole